KalVista Pharmaceuticals, Inc. (KALV)

SEC filing

KalVista Pharmaceuticals, Inc.

KALV · CIK 1348911

4 · Mar 10, 2026 · Palleiko Benjamin L sold 6,693 shares at $16.08/share ($107.6K); exercised options for 15.63K shares

Palleiko Benjamin L sold 6,693 shares at $16.08/share ($107.6K); exercised options for 15.63K shares

xslF345X05/form4-03102026_100330.xml

xslF345X05/form4-03102026_100330.xmlSEC.gov

Graphics and non-inline formats (not embedded below).